All News

FDA approved a single shared Risk Evaluation and Mitigation Strategy (REMS) for all mycophenolate-containing prescription drugs at the end of September.

The results of a recent survey may come as no surprise to many pharmacists-that time constraints can have an effect on the community practice setting and patient safety.

The Massachusetts Department of Health (DPH) announced Oct. 28 at a press conference that it will be adding five more inspectors to the Board of Pharmacy to continue its investigation of the New England Compounding Center, the Ameridose pharmacy, and other unannounced inspections at compounding pharmacies that prepare sterile injectables.

Cleansing laxatives approved for prescription use before colonscopy

A round-up of OTC products that help lips brave the winter weather.

A pharmacist describes an evening that he feels is typical of being a pharmacist and crystalizes how pharmacists are important.

Is your health system is having an epidemic of CLABSIs? CUSP can help save lives and money.

FDA and the CDC confirm that the fungus Exserohilium rostratum contaminated one of the three implicated lots of preservative-free methylprednisone acetate (80 mg/mL) from the New England Compounding Center which the company recalled September 26.

A look at how technology is changing the treatment of diabetes.

Anticoagulation therapies reviewed, including Merck moving forward with FDA approval of vorapaxar despite bleeding risks

A pharmacist reveals that the solution to all of pharmacy's problems: You get what you pay for.

A survey of new Rx, new generic, and new OTC products

Numerous health and safety violations related to the practice of pharmacy at the New England Compounding Center have been documented by investigators from the Massachusetts Department of Public Health and FDA.

Across the country, pharmacies are getting in the immunization game. Here are 10 steps to use for a successful program.

A recent IOM report indicates that the adoption of new technology is needed to reduce healthcare waste.

The National Association of Chain Drug Stores (NACDS) Foundation has invited General Colin L. Powell, the former U.S. Secretary of State and former chairman of the Joint Chiefs of Staff, as the keynote speaker for the 2012 NACDS Foundation dinner, which will be held in New York City on Nov. 27.

A look at the conditions that led to the recent fungal meningitis outbreak illustrate missed opportunities.

Among older adults with atrial fibrillation, persistence with warfarin therapy is generally lower than what has been reported in clinical trials, according to an online study in Archives of Internal Medicine.

The cost of medication for conditions that are the result of normal aging is greater than the cost of medication for most chronic conditions, according to a recent study from Express Scripts.

The FDA recalled the Symbiq pump touchscreen (Hospira Inc.) on Oct. 29. The screen may not properly respond to user selection, may have a delayed response, or register a value other than the one selected by the user, an FDA press release said.

The state Boards of Pharmacy have been lax in regulating the practices of compounding pharmacies, like the New England Community Center, Framingham, Mass., implicated in the fungal meningitis outbreak.

There is a famous proverb in foreign policy that states "the enemy of my enemy is my friend." This also rings true in a recent proposed settlement between retailers and credit card companies.

The National Community Pharmacists Association, other retail associations, and retailers, including Walmart and Target, are more than disappointed by the proposed settlement of a lawsuit that they brought against Visa, MasterCard, and several of the largest U.S. banks for allegedly conspiring to fix their credit card swipe fees.

FDA investigators issue a 483 form that details the filthy conditions at the NECC in Framingham, Mass., that has been implicated in the national meningitis outbreak.

The Centers for Disease Control and Prevention (CDC) has updated its recommendations for managing asymptomatic cases associated with the meningitis outbreak that has sickened 317 patients and been linked to the deaths of 24 in 17 states.

A Port Washington, N.Y. company recently had several dietary supplements and drugs seized by U.S. Marshals after the FDA determined the products had misleading labels and were not approved, according to an FDA press release.

The Advisory Committee for Immunization Practices (ACIP) voted to recommend the use of Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine (MenHibrix, GlaxoSmithKline) in infants at increased risk for bacterial meningitis.

FDA posted New England Compounding Center’s customer list, including all that received its products that were shipped on or after May 21 from its Framingham, Mass. facility, according to an FDA statement.

Patients with breakthrough cancer pain (BTCP) may want to consider intranasal fentanyl spray over oral agents to treat their breakthrough pain because of improved onset of analgesia and avoidance of nausea and vomiting, according to a report published online September 25 for The Annals of Pharmacotherapy.

Cardiac transplant patients may be at a higher risk for hospitalization due to drug-related problems than the general population, according to the report from a single cardiac transplant center, published the October issue of The Annals of Pharmacotherapy.